Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
52.76B | 48.37B | 44.45B | 39.71B | 39.34B | Gross Profit |
10.34B | 9.64B | 8.70B | 7.20B | 7.25B | EBIT |
5.12B | 5.00B | 4.46B | 3.48B | 3.56B | EBITDA |
6.22B | 5.44B | 5.33B | 4.42B | 3.79B | Net Income Common Stockholders |
3.73B | 3.33B | 3.24B | 2.63B | 2.42B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
15.79B | 11.79B | 12.80B | 11.50B | 9.97B | Total Assets |
39.71B | 33.64B | 33.14B | 30.34B | 26.77B | Total Debt |
2.39B | 1.03B | 1.57B | 1.92B | 2.56B | Net Debt |
-12.59B | -10.00B | -10.28B | -9.12B | -6.85B | Total Liabilities |
12.03B | 9.19B | 11.00B | 10.86B | 10.58B | Stockholders Equity |
27.68B | 24.45B | 22.13B | 19.49B | 16.19B |
Cash Flow | Free Cash Flow | |||
2.95B | 1.28B | 3.01B | 2.97B | 3.29B | Operating Cash Flow |
3.21B | 1.68B | 3.22B | 3.16B | 3.69B | Investing Cash Flow |
1.45B | -874.88M | -1.16B | -47.41M | 2.41M | Financing Cash Flow |
-723.69M | -1.63B | -1.35B | -1.48B | -511.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥3.19T | 34.29 | 22.20% | 1.08% | 3.84% | 19.26% | |
75 Outperform | $2.39T | 21.36 | 8.56% | 1.70% | 3.60% | 6.61% | |
74 Outperform | $46.63B | 11.28 | 15.16% | 3.31% | 11.21% | 23.03% | |
71 Outperform | ¥3.75T | 33.18 | 1.28% | 6.51% | -0.45% | ||
67 Neutral | ¥668.48B | 31.00 | 0.96% | 5.28% | 11.13% | ||
60 Neutral | $10.94B | 10.37 | -6.73% | 2.98% | 7.75% | -12.61% | |
56 Neutral | ¥210.02B | ― | -5.12% | 1.20% | 18.11% | -212.45% |